Weight gain, obesity, and metabolic indices following a first manic episode: prospective 12-month data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM). [electronic resource]
Producer: 20100823Description: 108-17 p. digitalISSN:- 1573-2517
- Adult
- Antimanic Agents -- adverse effects
- Antipsychotic Agents -- adverse effects
- Benzodiazepines -- adverse effects
- Bipolar Disorder -- blood
- Blood Glucose -- metabolism
- Body Mass Index
- Cholesterol -- blood
- Dibenzothiazepines -- adverse effects
- Female
- Follow-Up Studies
- Humans
- Insulin -- blood
- Lithium Carbonate -- adverse effects
- Male
- Obesity -- blood
- Olanzapine
- Overweight -- blood
- Prospective Studies
- Quetiapine Fumarate
- Risperidone -- adverse effects
- Triglycerides -- blood
- Valproic Acid -- adverse effects
- Weight Gain -- drug effects
- Young Adult
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.